A review of evidence for pneumococcal vaccination in adults at increased risk of pneumococcal disease: risk group definitions and optimization of vaccination coverage in the United Kingdom

Author:

Campling James1,Vyse Andrew1,Liu Hui-Hsuan2,Wright Hannah1,Slack Mary3,Reinert Ralf-Rene4,Drayson Mark5,Richter Alex5,Singh Dave6,Barlow Gavin7,Kassianos George89,Ellsbury Gillian1

Affiliation:

1. Medical Affairs, Pfizer Ltd, Walton Oaks, UK

2. Real-World Evidence, OPEN Health, London, UK

3. School of Medicine & Dentistry, Griffith University, Southport, Queensland, Australia

4. Medical Affairs, Pfizer Inc, Pfizer, Paris, France

5. Institute of Immunology and Immunotherapy, Medical School, University of Birmingham, Edgbaston, Birmingham, UK

6. Division of Immunology, Immunity to Infection and Respiratory Medicine, University of Manchester, Manchester, UK

7. Hull York Medical School, University of York, York, UK

8. Royal College of General Practitioners, London, UK

9. British Global & Travel Health Association, Bath, UK

Funder

Hui-Hsuan Liu at OPEN Health and was funded by Pfizer

Publisher

Informa UK Limited

Subject

Drug Discovery,Pharmacology,Molecular Medicine,Immunology

Reference131 articles.

1. Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory infections in 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016

2. World Health Organization. Pneumococcal conjugate vaccines in infants and children under 5 years of age: WHO position paper – February 2019. 2019. [cited 2022 December 02]. Available from: https://www.who.int/publications/i/item/10665-310968

3. UK Health Security Agency. Pneumococcal: the Green Book chapter 25. 2020 [cited2022 August 01]. Available from: https://www.gov.uk/government/publications/pneumococcal-the-green-book-chapter-25

4. Estimating the burden of adult hospital admissions due to RSV and other respiratory pathogens in England

5. Increasing Hospital Admissions for Pneumonia, England

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3